1920
A. BAZGIR AND A. M. ASTARAKI
456 (M+). Anal. Calcd. for C19H24N2O7S2: C, 49.99; H, 5.30; N, 6.14. Found: C, 49.83;
H, 5.22; N, 6.05.
Di-tert-butyl 2-(2,4,6-trioxotetrahydropyrimidin-5(6H)-ylidene)-1,3-dithiole-4,
◦
5-dicarboxylate (5f). White powder (yield 75%); mp > 300 C. IR: 30245, 2970, 2943,
1
1717, 1703, 1631. H NMR: δ 1.43 (18H, s, 6CH3), 9.32 (2H, bs, 2NH). MS: m/z 428
(M+). Anal. Calcd. for C17H20N2O7S2: C, 47.65; H, 4.70; N, 6.54. Found: C, 47.54; H,
4.76; N, 6.62.
Dimethyl 2-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,3-dithiole-
4,5-dicarboxylate (9a). Cream powder (yield 78%); mp 221 ◦C–223 ◦C. IR: 3087, 1719,
1705. 1H NMR: δ 2.23 (3H, s, CH3), 3.75 (3H, s, OCH3), 3.78 (3H, s, OCH3), 721–7.32
(5H, m, H-Ar). 13C NMR: δ 15.8, 50.3, 50.4, 117.5, 118.7, 126.7, 128.4, 139.3, 140.6,
146.2, 151.3, 165.2, 171.3. MS: m/z 390 (M+). Anal. Calcd. for C17H14N2O5S2: C, 52.30;
H, 3.61; N, 7.17. Found: C, 52.38; H, 3.55; N, 7.08.
Diethyl
2-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,3-dithiole-
4,5-dicarboxylate (9b). Cream powder (yield 74%); mp 213 ◦C–215 ◦C. IR: 3081, 1715,
1
3
1711. H NMR: δ 1.23 (6H, t, JHH = 7.11 Hz, 2CH3), 2.26 (3H, s, CH3), 4.11 (4H, m,
2CH2), 7.20–7.33 (5H, m, H-Ar). 13C NMR: δ 14.3, 16.2, 57.3, 57.5, 117.7, 117.9, 125.2,
128.7, 138.6, 140.1, 145.9, 151.7, 166.0, 171.1. MS: m/z 418 (M+). Anal. Calcd. for
C19H18N2O5S2: C, 54.53; H, 4.34; N, 6.69. Found: C, 54.41; H, 4.26; N, 6.60.
Di-tert-butyl 2-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-yl◦idene)-1,3-dithiole-
◦
4,5-dicarboxylate (9c). White powder (yield 68%); mp 232 C–234 C. IR: 3078, 1719,
1714. 1H NMR: δ 1.41 (18H, s, 6CH3), 2.29 (3H, s, CH3), 7.18–7.25 (5H, m, H-Ar). 13
C
NMR: δ 15.7, 28.3, 69.7, 116.4, 117.5, 125.9, 127.5, 138.1, 141.4, 145.3, 151.0, 166.5,
171.7. MS: m/z 474 (M+). Anal. Calcd. for C23H26N2O5S2: C, 58.21; H, 5.52; N, 5.90.
Found: C, 58.31; H, 5.46; N, 5.99.
Di-tert-butyl 2-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,3-dithiole-
4,5-dicarboxylate (11). White powder (yield 48%); IR: 3023, 1714, 1709, 1704. 1H NMR:
δ 3.87 (3H, s, CH3), 3.91 (3H, s, CH3), 7.31–7.54 (10H, m, H-Ar). 13C NMR: δ 50.3, 50.4,
120.2, 127.5, 127.8, 128.3, 132.5, 134.8, 138.7, 138.9, 139.2, 167.9, 178.5. MS: m/z 412
(M+). Anal. Calcd. for C21H16O5S2: C, 61.15; H, 3.91. Found: C, 61.23; H, 3.84.
REFERENCES
1. A. Choudhury, H. Chen, C. N. Nilsen, and K. L. Sorgi, Tetrahedron Lett., 49, 102 (2008).
2. M. Brndvang and L. L. Gundersen, Tetrahedron Lett., 48, 3057 (2007).
3. U. Girreser, D. Heber, and M. Schutt, Tetrahedron, 60, 11511 (2004).
4. N. Baudet and P. Knochel, Org. Lett., 8, 3737 (2006).
5. P. G. Baraldi, A. Bovero, F. Fruttarolo, R. Romagnolo, M. A. Tabrizi, D. Preti, K. Varani, P. A.
Borea, and A. R. Moorman, Bioorg. Med. Chem., 11, 4161 (2003).
6. N. K. Terrett, A. S. Bell, D. Brown, and P. Ellis, Bioorg. Med. Chem. Lett., 6, 1819 (1996).
7. J. Elguero, In Comprehensive Heterocyclic Chemistry II, A. R. Katritzky, C. W. Rees, and E. F.
Scriven, Eds. (Elsevier, Oxford, 1996), Vol 3, pp. 1–75.
8. S. K. Singh, P. G. Reddy, K. S. Rao, B. B. Lohray, P. Misra, S. A. Rajjak, Y. K. Rao, and A.
Venkatewarlu, Bioorg. Med. Chem. Lett., 14, 499 (2004).
9. M. Barcelo, E. Ravina, C. F. Masaguer, E. Dominguez, F. M. Areias, J. Brea, and M. I. Loza,
Bioorg. Med. Chem. Lett., 17, 4873 (2007).
10. C. F. Marcos, C. Polo, O. A. Rakitin, C. W. Rees, and T. Torroba, Chem. Commun., 879 (1997).
11. J. L. Segura and N. Martin, Angew. Chem. Int. Ed., 40, 1372 (2001).
12. M. R. Bryce, J. Mater. Chem., 5, 1481 (1995).